HPV/Cervical Pre-cancer Surveillance (HPV-Impact)

HPV

HPV Image by Dr Arvind Varsani, Electron Microscope Unit, University of Cape Town. Released into the public domain by Equal Treatment magazine.

Overview

The introduction in 2006 of a highly effective vaccine against human papillomavirus (HPV) exposed the need for population-based surveillance of HPV-related diseases. In 2007, the Centers for Disease Control and Prevention funded a collaboration between CEIP and the California Department of Public Health STD Control Branch to develop a comprehensive plan to conduct surveillance of cervical pre-cancer including cervical intraepithelial neoplasia (CIN) 2/3 and adenocarcinoma in situ (AIS). This surveillance effort is ongoing in Alameda County, California.

Objectives

  • Determine the burden of CIN 2/3 and AIS in Alameda County and monitor trends in incidence
  • Conduct HPV testing for a subset of cases to monitor HPV types
  • Monitor and evaluate the impact of the HPV vaccines

Laboratory Reporting

As of September 23, 2013, high-grade cervical pre-cancer is reportable in Alameda County. Please see additional information on reporting eligible cases.

Newsletter

HPV-Impact produces an annual newsletter about the surveillance effort, HPV in the news, and findings to date. Please read more below.


If you would like to be added to the HPV-Impact newsletter mailing list, enter your information below:

Privacy by SafeUnsubscribe

In the News

Relevant Documents

A printable two-page summary of HPV-Impact
hpv.impact.timeline.p1

How is information requested? See a sample case report form that may be faxed to providers.

National Collaborating Surveillance Sites and Participating Institutions

  • Alameda County Public Health Department
  • Connecticut Emerging Infections Program, Yale University
  • Tennessee Department of Health, Tennessee Emerging Infections Program, Vanderbilt University
  • New York Emerging Infections Program, University of Rochester
  • Oregon Emerging Infections Program, State of Oregon Department of Human Services
  • Kaiser Permanente of Northern California

Questions?

Please contact:

  • Ina Park, MD MS
    Medical Director for the California Prevention Training Center
    Associate Professor, UCSF School of Medicine
    ina.park@ucsf.edu
    (510) 625-6012
  • Erin Whitney, MPH
    HPV Surveillance Project Coordinator
    STD Control Branch, California Department of Public Health
    850 Marina Bay Parkway, Bldg P, 2nd Floor
    Richmond, CA 94804
    erin.whitney@cdph.ca.gov
    (510) 620-2379

Links

For more information on HPV and the HPV vaccine: